---
layout: post
title: "FDA's Strategy Document on Innovative Manufacturing Technologies"
date: 2026-02-04 21:36:58 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-21692
original_published: 2025-12-01 00:00:00 +0000
significance: 8.00
---

# FDA's Strategy Document on Innovative Manufacturing Technologies

**Published:** February 04, 2026 21:36 UTC
**Source:** Federal Register
**Original Published:** December 01, 2025 00:00 UTC
**Document Number:** 2025-21692

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the publication of FDA's Strategy Document on Innovative Manufacturing Technologies (Strategy Document), which outlines specific actions FDA has taken and the Agency's plans for fiscal years 2023-2027 to facilitate the use of innovative manufacturing technologies. As part of the Prescription Drug User Fee Act (PDUFA) Reauthorization Performance Goals and Procedures Fiscal Years 2023-2027 (PDUFA VII), FDA committed to advance the use and implementation of innovative manufacturing. The actions described in the Strategy Document are based on lessons learned from FDA's experiences with submissions involving advanced manufacturing technologies as well as public input.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/12/01/2025-21692/fdas-strategy-document-on-innovative-manufacturing-technologies)
- API: https://www.federalregister.gov/api/v1/documents/2025-21692

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
